Parallax Volatility Advisers, L.P. Novartis Ag Transaction History
Parallax Volatility Advisers, L.P.
- $49.8 Billion
- Q4 2024
A detailed history of Parallax Volatility Advisers, L.P. transactions in Novartis Ag stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 803 shares of NVS stock, worth $89,518. This represents 0.0% of its overall portfolio holdings.
Number of Shares
803
Previous 9,700
91.72%
Holding current value
$89,518
Previous $1.12 Million
93.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding NVS
# of Institutions
1,480Shares Held
130MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.36 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.23 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$912 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$766 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$622 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $240B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...